Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.
Press releases published on July 29, 2025
Robb Report Names Matchmaker For Private Jet Programs Private Jet Card Comparisons' Doug Gollan To ‘Masters Of Luxury’
EIN Presswire
·
July 29, 2025
Luxury lifestyle magazine Robb Report has named the founder and editor of Private Jet Card Comparisons, Doug Gollan, to its 'Masters of Luxury' for aviation. MIAMI, FL, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- The founder and principal of a …
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
GlobeNewswire
·
July 29, 2025
DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 …
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
GlobeNewswire
·
July 29, 2025
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …
DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025
GlobeNewswire
·
July 29, 2025
Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …
Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
GlobeNewswire
·
July 29, 2025
– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg onvansertib dose arm vs. control arm – – Onvansertib …
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
July 29, 2025
REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Canaccord …
Varonis Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
July 29, 2025
Annual recurring revenues grew 19% year-over-year SaaS ARR as a percentage of total ARR was approximately 69% Year-to-date cash from operations generated $89.3 million vs. $68.4 million last year Year-to-date free cash flow generated $82.7 million vs. $67. …
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire
·
July 29, 2025
SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday, Aug. 5, 2025. The …
Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
GlobeNewswire
·
July 29, 2025
- Appointed Dr. Roger Sidhu as Chief Medical Officer - - Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) - - Announced …
EXL announces $125 million accelerated share repurchase program
GlobeNewswire
·
July 29, 2025
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, today announced that, as part of its capital allocation program, it has entered into an accelerated share repurchase agreement (the “ASR”) with Citibank, N.A. to …
Larimar Therapeutics Announces Proposed Underwritten Public Offering
GlobeNewswire
·
July 29, 2025
BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an …
Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints
GlobeNewswire
·
July 29, 2025
- Primary Endpoint Analysis Confirms Favorable Tolerability Profile of ATI-2138 Without Certain Risks Associated with Other Agents in the Class - - Efficacy Results Show Comparable Outcomes to Approved Therapies with Potential for Improved Tolerability, …
EXL Reports 2025 Second Quarter Results
GlobeNewswire
·
July 29, 2025
2025 Second Quarter Revenue of $514.5 Million, up 14.7% year-over-year Q2 Diluted EPS (GAAP) of $0.40, up 43.9% from $0.28 in Q2 of 2024 Q2 Adjusted Diluted EPS (Non-GAAP) (1) of $0.49, up 20.3% from $0.40 in Q2 of 2024 NEW YORK, July 29, 2025 (GLOBE …
Qorvo® Announces Fiscal 2026 First Quarter Financial Results
GlobeNewswire
·
July 29, 2025
GREENSBORO, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading global provider of connectivity and power solutions, today announced financial results for the Company’s fiscal 2026 first quarter ended June 28, 2025. On a GAAP basis, …
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
GlobeNewswire
·
July 29, 2025
Cash and cash equivalents at €122.1 million and €24.6 million in short-term deposits2 as of June 30, 2025 Revenues of €4.5 million recorded in H1 2025 Daix (France), New York City (New York, United States), July 29, 2025 – Inventiva (Euronext Paris and …
Inventiva publie ses informations financières préliminaires du premier semestre 2025¹
GlobeNewswire
·
July 29, 2025
Trésorerie et équivalents de trésorerie de 122,1 millions d’euros et 24,6 millions d’euros de dépôts à court terme2 au 30 juin 2025 Chiffre d’affaires de 4,5 millions d’euros au premier semestre 2025 Daix (France), New York City (New York, Etats-Unis), le …
Locus Unveils OneView™: A Unified Command Center for EHS Compliance and ESG Performance
GlobeNewswire
·
July 29, 2025
MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Locus Technologies, the pioneer in cloud-based environmental compliance and sustainability software, today announced the release of Locus OneView, a powerful new application that unifies data from …
Snov.io Doubles Sending Limits as Outreach Teams Scale 23x Faster in 2025
GlobeNewswire
·
July 29, 2025
New York, NY, July 29, 2025 (GLOBE NEWSWIRE) -- Snov.io, a multichannel lead generation and sales automation platform, reports that 34% more users are automating their outreach in 2025 compared to the previous year. This trend highlights an accelerating …
Andrew Cardno to Present on Resilient Casino Strategies at the 2025 Casino Marketing & Technology Conference
GlobeNewswire
·
July 29, 2025
SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) is proud to announce that Andrew Cardno, Co-Founder and Chief Technology Officer, will be a featured speaker at the upcoming Casino Marketing …
Hematologist Dissatisfaction with Current Warm Autoimmune Hemolytic Anemia (w-AIHA) Treatment Spurs Interest in Late-Stage Pipeline, According to Spherix Global Insights
GlobeNewswire
·
July 29, 2025
EXTON, PA, July 29, 2025 (GLOBE NEWSWIRE) -- According to new findings from Spherix Global Insights’ syndicated Market Dynamix™ service, hematologists managing patients with warm autoimmune hemolytic anemia (w-AIHA) continue to face clinical complexity, a …